PSEUDOTUBERCULOSIS AND INTESTINAL YERSINIOSIS: THE ADVANCEMENT OF NONSPECIFIC PROPHYLAXIS AND THERAPY
https://doi.org/10.21886/2219-8075-2017-1-28-31
Abstract
Recent years have witnessed the development and clinical implementation of the new approaches to prophylaxis and treatment of different nosological forms of diseases – combination of conventional therapy and immunocorrection. The review analyzes present-day state of nonspecific prophylaxis and treatment of pseudotuberculosis and intestinal yersiniosis. Information is presented on the effectiveness of immunomodulators, products of vital activity of plant cells and sea creatures, prebiotics, immunoglobuline complex (CIP) in prophylaxis and therapy of these diseases.
About the Authors
A. V. Filippenko
Rostov-on-Don Institute for Plague Control
Russian Federation
117 M. Gorky Str., Rostov-on-Don 344002, Russia
Russian Federation
117 M. Gorky Str., Rostov-on-Don 344002, Russia
I. A. Ivanova
Rostov-on-Don Institute for Plague Control
117 M. Gorky Str., Rostov-on-Don 344002, Russia
117 M. Gorky Str., Rostov-on-Don 344002, Russia
I. V. Morozova
Rostov-on-Don Institute for Plague Control
117 M. Gorky Str., Rostov-on-Don 344002, Russia
117 M. Gorky Str., Rostov-on-Don 344002, Russia
N. D. Omelchenko
Rostov-on-Don Institute for Plague Control
117 M. Gorky Str., Rostov-on-Don 344002, Russia
117 M. Gorky Str., Rostov-on-Don 344002, Russia
N. I. Pasyukova
Rostov-on-Don Institute for Plague Control
117 M. Gorky Str., Rostov-on-Don 344002, Russia
117 M. Gorky Str., Rostov-on-Don 344002, Russia
A. L. Trukhachev
Rostov-on-Don Institute for Plague Control
117 M. Gorky Str., Rostov-on-Don 344002, Russia
117 M. Gorky Str., Rostov-on-Don 344002, Russia
I. A. Bespalova
Rostov-on-Don Institute for Plague Control
117 M. Gorky Str., Rostov-on-Don 344002, Russia
117 M. Gorky Str., Rostov-on-Don 344002, Russia
References
1. Yuschuk ND. Yersinioses. Moscow: Medicine; 2003 (in Russ).
2. Zheleznikova GF, Bekhtereva MK. Enteropathogenic Yersinia and host cytokine system. Zh. Mikrobiol. 2010;6:112-121 (in Russ).
3. Timchenko NF, Terentjev LL, Nedashkovskaya OI, Raznik NV, Rasskazov VA. Effect of Yersinia pseudotuberculosis thermostable toxin on DNA, RNA and protein biosynthesis in eukaryotic cells. Zhurnal epidemiologii i infektsionnykh bolezney. 2002;(1):22-25 (in Russ).
4. Reznikov YuP. Immunocorrective therapy at the turn of the millanea. Moscow: Medicine; 2001 (in Russ).
5. Khaitov PM, Pinegin BV, Andronova TM. Domestic immunotropic drugs of the latest generation and the strategy of their application. Pediatricheskaya farmakologiya. 2002:20- 24 (in Russ).
6. Plotnikov KP. Thymogen application in pseudotuberculosis comprehensive therapy. Actual problems of chemotherapy of bacterial infections: Abstracts of reports. Moscow, 1991:504 -505 (in Russ).
7. Burgasova OA, Yuschuk ND, Voskresenskays EA, Tseneva GYa. Protective effect of the drug “Bestim” in the course of experimental pseudotuberculosis infection. Zdorovje natsii i sreda obitaniya. 2011;(6):27-29 (in Russ).
8. Goryacheva LG, Botvinyeva VV, Romantsov MG. The use of cycloferon in pediatrics. Moscow-St.-P.; 2004. (in Russ).
9. Kvetnaya AS, Bekhtereva MK, Zheleznova LI, Kalinogorskaya OS. cycloferon use in complex therapy of children with salmonellosis and yersiniosis infection. Antibiotiki i khimioterapiya. 2012;57(3- 4):9-16 (in Russ).
10. Beniova SN, Markelova EV. Immunocorrection in recurrent Yersinia pseudotuberculosis infection in children. Tsitokiny i vospaleniye. 2003;2(3):13-17 (in Russ).
11. Tseneva GYa, Demakova TE, Simbirtsev AS et al. Effect of the recombinant 1β interleukin on experimental pseudotuberculosis process. Infectious diseases: Current problems of diagnostics and therapy: Russian scientific and practical conference. Moscow-St. Petersburg, 2008;282-283 (in Russ).
12. Feklisova LV, Galkina LA. Assessement of sodium nucleate introduction into the complex therapy of children with yersiniosis. Infections associated with Yersinia: Proceedings of the International Conference. St. Petersburg, 2000; 60 (in Russ).
13. Dubrovina VI, Golubinsky EP, Borsuk GI et al. Phagocytosis correction in Yersinia pseudotuberculosis infection by immunomodulators of natural origin. Infections associated with yersinia. Proceedings of the International Conference. St. Petersburg, 2000; 19 (in Russ).
14. Zaporozhets TS, Krylova NV, Ivanushko LA et al. Correction of phagocytosis defects in Yersinia pseudotuberculosis by immunomodulators of natural origin. Zhurnal mikrobiologii. 1997;(5):55- 58 (in Russ).
15. Dolmatova LS, Zaika OA, Timchenko NF. Effect of the Far Eastern holothurian extract in different ways of application (при различных способах применения) on the functional activity of peritoneal macrophages in mice inoculated by Yersinia pseudotuberculosis. Infections associated with yersinia. Proceedings of the III All-Russian Scientific and Practical Conference. St. Petersburg, 2011:52-53 (in Russ.).
16. Bondarenko VM, Likhoded VG. The ideas of I.I. Mechnikov and modern human intestine microecology. Zhurnal mikrobiologii. 2008;(5):23-29 (in Russ).
17. Chicherin IYu, Pogorelsky IP, Lundovskikh IA, Darmov IA, Marakulin IV. Assessing the possibility of prevention, treatment and correction of the intestinal microflora dysbiotic disorders in experimental pseudotuberculosis. Zhurnal infektologii. 2012;4(4):71-79 (in Russ).
18. Chicherin IYu, Pogorelsky IP, Lundovskikh IA, Bessolitsyna EA, Darmov IV, Shabalina MR. Colonization resistance of the intestinal mucosa in experimental yersiniosis. Zhurnal infektologii. 2013;5(1):75-82 (in Russ).
19. Bondarenko VM, Gracheva NM. Probiotics, prebiotics and synbiotics in therapy and prevention of intestinal dysbioses. Farmateka. 2003;(7):56-63 (in Russ).
20. Dobritsa VP, Boterashvili NM, Dobritsa EV. Present-day immunomodulators for clinical application. Manual for Medical Practitioners. Politekhnika, 2001 (in Russ.).
21. Kopanev YuA, Sokolov AL, Aleshkin VA et al. The effect of immunoglobuline complex on opportunistic flora. Vrach. 1998;(5):38 (in Russ).
22. Gracheva NM, Petrov MS, Avakov AA, Partii OS. Immunoglobulin preparations for enteral usage in treatment practices for children and adults. Novye lekarstvennye preparaty. 2003; (4):33-42 (in Russ).
23. Filippenko AV, Morozova IV, Ivanova IA et al. Effect of immunoglobuline complex (CIP) on the course of experimental infections caused by members of Yersinia genus. Immunopathology and immunorehabilitation: from theory to practice. Proceedings of All- Russian Scientific and Practical Conference. Penza, 2015:79-80 (in Russ.).
24. Doroshenko EP, Omelchenko ND, Morozova IV. A new approach to treatment of pseudotuberculosis infection. Infektsionnye bolezni. 2015;13(Appendix 1):113 (in Russ).
25. Ivanova IA, Morozova IV, Filippenko AV et al. Effect of immunoglobuline complex on development, course and outcome of experimental intestinal yersiniosis. Meditsinskaya immunologiya. 2015;17(3):267-268 (in Russ).
26.
Review
For citations:
Filippenko A.V., Ivanova I.A., Morozova I.V., Omelchenko N.D., Pasyukova N.I., Trukhachev A.L., Bespalova I.A. PSEUDOTUBERCULOSIS AND INTESTINAL YERSINIOSIS: THE ADVANCEMENT OF NONSPECIFIC PROPHYLAXIS AND THERAPY. Medical Herald of the South of Russia. 2017;(1):28-31. (In Russ.) https://doi.org/10.21886/2219-8075-2017-1-28-31
Views:
2131
Email this article 